Palliative Radiation

RADIATION2 trials

Sponsors

David Palma, University of Wisconsin, Madison

Conditions

Head and Neck CancerMetastatic Tumors

Phase 2

Bempegaldesleukin (NKTR-214) With Radiation and Anti-PD-1 Immunotherapy for Head and Neck Squamous Cell Carcinoma

TerminatedNCT04936841

University of Wisconsin, MadisonHead and Neck Cancer

Start: 2021-08-05End: 2022-10-04Updated: 2024-04-04

Phase 3

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors

Active, not recruitingNCT03721341

David PalmaMetastatic Tumors

Start: 2019-02-22End: 2029-01-31Updated: 2025-09-18

Related Papers

Multimodality local consolidative treatment versus conventional care of advanced lung cancer after first-line systemic anti-cancer treatment: study protocol for the RAMON multicentre randomised controlled trial with an internal pilot

BMJ Open2023-12-011 citations

Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer

Future Oncology2023-05-185 citations

A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

BMC Cancer2020-06-0132 citations

Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.

2019-08-19190 citations